跳至主要内容
临床试验/NCT07639931
NCT07639931尚未招募不适用

Integration and Application Demonstration of Key Diagnosis and Treatment Technologies for Severe Acute High Altitude Disease

Tibet Autonomous Region People's Hospital1 个研究点 分布在 1 个国家目标入组 3,035 人开始时间: 2026年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
3,035
试验地点
1

研究概览

简要总结

This study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy through multicenter studies, and innovate diagnostic and therapeutic technologies. It will achieve early identification, precise diagnosis, standardized treatment, and intelligent warning of severe acute mountain sickness, comprehensively improving its prevention, control and treatment success rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meeting the diagnostic criteria for severe acute mountain sickness (including high-altitude pulmonary edema [HAPE] and high-altitude cerebral edema [HACE]).
  • Aged 18 to 75 years.
  • Rapid ascent to an altitude above 2500 m within 72 hours prior to onset.

排除标准

  • History of severe cardiopulmonary diseases.
  • Pregnant women, patients with psychiatric disorders, inability to cooperate with treatment or follow-up, and patients with an expected survival of less than 6 months.
  • Patients with malignant tumors, severe hepatic or renal insufficiency, or immune system diseases requiring immunosuppressive therapy.

研究者

发起方
Tibet Autonomous Region People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gesang Lobb

First-Class Chief Physician, Department of Cardiovascular Medicine

Tibet Autonomous Region People's Hospital

研究点 (1)

Loading locations...

相似试验